Nimenrix Injection 0.5ml

About Nimenrix Injection 0.5ml

Nimenrix Injection 0.5ml Uses

• Active immunization against invasive meningococcal disease caused by Neisseria meningitidis groups A, C, W-135 and Y
• Recommended for infants from 6 weeks of age, children, adolescents and adults
• Given to travelers visiting regions with high meningococcal risk, including for Hajj and Umrah requirements
• Used for close contacts of a confirmed meningococcal meningitis case as advised by a doctor

Nimenrix Injection 0.5ml Benefits

• Covers four major meningococcal serogroups in a single vaccine
• Provides long lasting immune protection with a strong antibody response
• Single dose or short primary series depending on age at vaccination
• Meets Saudi Arabia entry requirements for Hajj and Umrah pilgrims

What Experts Say

Nimenrix is a conjugate vaccine that combines capsular polysaccharides from meningococcal groups A, C, W-135 and Y with a tetanus toxoid protein carrier. This conjugation improves the immune response, especially in young children, and helps create longer lasting immune memory compared to older polysaccharide only vaccines.

Meningococcal disease can progress very quickly from fever to severe complications such as meningitis or bloodstream infection within hours. Vaccination is an important preventive step, particularly for infants, students living in shared accommodation, and travelers heading to regions with seasonal outbreaks or mass gatherings.

The vaccination schedule depends on age at first dose, ranging from a two dose primary series in early infancy to a single dose in older children, adolescents and adults. A booster may be recommended for people at continued risk of exposure, and the vaccine is usually given as an injection into the muscle of the thigh or upper arm.

Drug Class

• Conjugate Vaccine

Nimenrix Injection 0.5ml formula

• Meningococcal Groups A, C, W-135 and Y Conjugate Vaccine

Available forms

• Injection

How to use Nimenrix Injection 0.5ml?

• Nimenrix is given only by a doctor or trained healthcare professional
• It is administered as an injection into the muscle, usually the thigh for infants or the upper arm for older children and adults
• Follow the exact dosing schedule recommended for the age at first vaccination
• Complete all recommended doses for full protection
• Inform your doctor of any previous vaccine reactions before the injection

Drug Interactions

• Immunosuppressive Therapy: Can reduce the antibody response to the vaccine
• Other Injectable Vaccines: Can generally be given at the same visit but at separate injection sites, confirm timing with your doctor
• Blood Thinners: May increase the risk of bruising or bleeding at the injection site

Risks and warnings

• Allergic Reactions: Avoid if there is a known severe allergy to any component of the vaccine or to tetanus toxoid
• Fever Illness: Postpone vaccination if there is a moderate to severe acute illness with high fever
• Bleeding Disorders: Use with caution in patients with clotting problems or on blood thinners, since intramuscular injection can cause bruising
• Fainting Risk: Some people, especially adolescents, may faint after injection, so a short observation period is advised
• Immunocompromised Patients: May have a reduced immune response to the vaccine
• Pregnancy and Breastfeeding: Use only if clearly needed, based on risk of exposure and medical advice

Nimenrix Injection 0.5ml Side Effects

• Pain, redness or swelling at the injection site
• Mild fever
• Irritability in infants and young children
• Drowsiness or reduced appetite
• Headache
• Fatigue
• Nausea or vomiting
• Muscle or joint pain
• Dizziness
• Allergic reaction in rare cases

Storage Conditions

• Store in a refrigerator between 2 and 8 degrees Celsius
• Keep the pre filled syringe or vial in its outer carton to protect from light
• Do not freeze, and discard the vaccine if it has been frozen
• Keep out of reach of children
• Use immediately after reconstitution when a separate vial and diluent are supplied